News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Craig Adam R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 900,000 options to buy
@ $4.55, valued at
$4.1M
|
|
| 01/26/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 83,200 shares
@ $6, valued at
$499.2k
Sold 2,117 shares
@ $6.01, valued at
$12.7k
Exercised 83,200 options to buy
@ $0.8411, valued at
$70k
Exercised 2,117 options to buy
@ $0.8411, valued at
$1.8k
|
|
| 01/03/2023 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 13,800 shares
@ $6, valued at
$82.8k
Granted 1,579 shares
@ $5.1085, valued at
$8.1k
Sold 12,000 shares
@ $6, valued at
$72k
Sold 700 shares
@ $6.005, valued at
$4.2k
Sold 4,400 shares
@ $6.01, valued at
$26.4k
Sold 84,683 shares
@ $6.0133, valued at
$509.2k
Exercised 13,800 options to buy
@ $0.8411, valued at
$11.6k
Exercised 12,000 options to buy
@ $0.8411, valued at
$10.1k
Exercised 700 options to buy
@ $0.8411, valued at
$588.8
Exercised 4,400 options to buy
@ $0.8411, valued at
$3.7k
Exercised 84,683 options to buy
@ $0.8411, valued at
$71.2k
|
|
| 11/14/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 46,100 shares
@ $6, valued at
$276.6k
Sold 7,596 shares
@ $6.01, valued at
$45.7k
Sold 300 shares
@ $6.015, valued at
$1.8k
Sold 136,408 shares
@ $6, valued at
$818.4k
Sold 200 shares
@ $6.005, valued at
$1.2k
Sold 26,700 shares
@ $6.01, valued at
$160.5k
Sold 100 shares
@ $6.015, valued at
$601.5
Sold 16,396 shares
@ $6.02, valued at
$98.7k
Sold 5,800 shares
@ $6.03, valued at
$35k
Sold 2,700 shares
@ $6.04, valued at
$16.3k
Exercised 53,996 options to buy
@ $0.8411, valued at
$45.4k
|
|
| 09/14/2022 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 242,300 shares
@ $6.43, valued at
$1.6M
Exercised 242,300 options to buy
@ $0.8411, valued at
$203.8k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2019 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 1,300,000 options to buy
@ $0.8411, valued at
$1.1M
|
|
| 09/20/2018 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 600,000 options to buy
@ $1.88, valued at
$1.1M
|
|
| 05/17/2018 |
4
| Craig Adam R (President and CEO) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 475,000 options to buy
@ $4.14, valued at
$2M
|
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/02/2015 |
4
| Craig Adam R (EVP, Development & CMO) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 19,031 shares
@ $0
Paid exercise price by delivering 8,302 shares
@ $2.22, valued at
$18.4k
|
|
| 11/03/2014 |
4
| Craig Adam R (EVP, Development & CMO) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 140,000 options to buy
@ $1.7, valued at
$238k
|
|
| 08/29/2014 |
4
| Craig Adam R (EVP, Development & CMO) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Sold 2,554 shares
@ $8, valued at
$20.4k
|
|
| 03/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2012 |
4
| Craig Adam R (EVP, Development & CMO) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 600,000 options to buy
@ $1.74, valued at
$1M
|
|
| 03/02/2012 |
3
| Craig Adam R (EVP, Development & CMO) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
|
|